Moreover, only a few DNA methylation biomarkers intended for CRC detection are commercially available, including ColoVantage®, EpiproColon® 2.0 and Abbott RealTime mS9, which are blood-based tests based on septin 9 (SEPT9) promoter methylation [12, 18]. The gene discussed is SEPTIN9; the disease is colorectal carcinoma.